---
$id: https://graph.org.ai/products/commodity/51181610
$type: Product
source: UNSPSC
code: "51181610"
title: "Montirelin"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Montirelin

**UNSPSC Code**: 51181610
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thyrotropin-releasing hormone analogue with the molecular formula C17H24N6O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30MUJ6YYUY, chemically known as (-)-n-(((3r,6s)-6-methyl-5-oxo-3-thiomorpholinyl)carbonyl)-l-histidyl-l-prolinamide but generally known as montirelin, which bears US NIH Compound Identifier 65815. European Medicines Agency schedules Montirelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09056MIG. The term MONTIRELIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). MONTIRELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule montirelin under HS 29371900 and SITC 54154. As of Q4 2014, MONTIRELIN remains the US FDA Preferred Term for this commodity. Montirelin bears US NLM identifiers UMLS ID C0377440 and NCI Concept Code C77010. SMILES: S1CC(NC(=O)C1C)C(=O)NC(C(=O)N1C(CCC1)C(=O)N)CC1[NH]CNC1.

